Cargando…
Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype
In BRAF(V600E) melanoma cells, a global metabolomic analysis discloses a decrease in nicotinamide adenine dinucleotide (NAD(+)) levels upon PLX4032 treatment that is conveyed by a STAT5 inhibition and a transcriptional regulation of the nicotinamide phosphoribosyltransferase (NAMPT) gene. NAMPT inhi...
Autores principales: | Ohanna, Mickaël, Cerezo, Mickaël, Nottet, Nicolas, Bille, Karine, Didier, Robin, Beranger, Guillaume, Mograbi, Baharia, Rocchi, Stéphane, Yvan-Charvet, Laurent, Ballotti, Robert, Bertolotto, Corine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900716/ https://www.ncbi.nlm.nih.gov/pubmed/29567766 http://dx.doi.org/10.1101/gad.305854.117 |
Ejemplares similares
-
SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells
por: Ohanna, Mickaël, et al.
Publicado: (2014) -
E2F1 inhibition mediates cell death of metastatic melanoma
por: Rouaud, Florian, et al.
Publicado: (2018) -
Focus on cutaneous and uveal melanoma specificities
por: Pandiani, Charlotte, et al.
Publicado: (2017) -
ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
por: Cheli, Yann, et al.
Publicado: (2021) -
Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
por: Cheli, Yann, et al.
Publicado: (2021)